Free Trial
NASDAQ:GUTS

Fractyl Health (GUTS) Stock Price, News & Analysis

Fractyl Health logo
$0.99 0.00 (-0.04%)
Closing price 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+1.01%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Fractyl Health Stock (NASDAQ:GUTS)

Key Stats

Today's Range
$0.98
$1.04
50-Day Range
$0.96
$2.14
52-Week Range
$0.83
$3.72
Volume
544,034 shs
Average Volume
1.44 million shs
Market Capitalization
$49.79 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.53
Consensus Rating
Buy

Company Overview

Fractyl Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
47th Percentile Overall Score

GUTS MarketRank™: 

Fractyl Health scored higher than 47% of companies evaluated by MarketBeat, and ranked 578th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Fractyl Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Fractyl Health has only been the subject of 2 research reports in the past 90 days.

  • Read more about Fractyl Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Fractyl Health are expected to decrease in the coming year, from ($1.61) to ($1.81) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Fractyl Health is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Fractyl Health is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Fractyl Health's valuation and earnings.
  • Percentage of Shares Shorted

    9.58% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fractyl Health has recently increased by 5.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Fractyl Health does not currently pay a dividend.

  • Dividend Growth

    Fractyl Health does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    9.58% of the float of Fractyl Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Fractyl Health has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Fractyl Health has recently increased by 5.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Fractyl Health has a news sentiment score of 1.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Fractyl Health this week, compared to 2 articles on an average week.
  • Search Interest

    7 people have searched for GUTS on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Fractyl Health to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Fractyl Health insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    27.00% of the stock of Fractyl Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Fractyl Health's insider trading history.
Receive GUTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fractyl Health and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GUTS Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.tc pixel
6GUTS : An Overview of Fractyl Health's Earnings
See More Headlines

GUTS Stock Analysis - Frequently Asked Questions

Fractyl Health's stock was trading at $2.06 on January 1st, 2025. Since then, GUTS shares have decreased by 51.9% and is now trading at $0.99.

Fractyl Health, Inc. (NASDAQ:GUTS) released its earnings results on Tuesday, August, 12th. The company reported ($0.53) earnings per share for the quarter, missing the consensus estimate of ($0.37) by $0.16. Fractyl Health had a negative net margin of 73,864.52% and a negative trailing twelve-month return on equity of 584.35%.
Read the conference call transcript
.

Fractyl Health (GUTS) raised $110 million in an IPO on Friday, February 2nd 2024. The company issued 7,333,333 shares at a price of $15.00 per share.

Top institutional investors of Fractyl Health include General Catalyst Group Management LLC (9.97%), Y Intercept Hong Kong Ltd (0.23%), Geode Capital Management LLC (0.23%) and Qube Research & Technologies Ltd (0.16%). Insiders that own company stock include Ajay Royan, Harith Rajagopalan, Jay David Caplan and William Bradley.
View institutional ownership trends
.

Shares of GUTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Fractyl Health investors own include SoFi Technologies (SOFI), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Alphabet (GOOG), JPMorgan Chase & Co. (JPM) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
8/12/2025
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:GUTS
Previous Symbol
NASDAQ:GUTS
CIK
1572616
Fax
N/A
Employees
102
Year Founded
N/A

Price Target and Rating

High Price Target
$10.00
Low Price Target
$3.60
Potential Upside/Downside
+554.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$68.69 million
Net Margins
-73,864.52%
Pretax Margin
-586,864.69%
Return on Equity
-584.35%
Return on Assets
-102.88%

Debt

Debt-to-Equity Ratio
4.61
Current Ratio
1.22
Quick Ratio
1.22

Sales & Book Value

Annual Sales
$17 thousand
Price / Sales
2,955.22
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.36) per share
Price / Book
-2.78

Miscellaneous

Outstanding Shares
50,289,000
Free Float
36,711,000
Market Cap
$50.24 million
Optionable
N/A
Beta
1.66

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:GUTS) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners